Methods_____number was measured by in vitro bioassay, and a sample of 22 kDa C-terminal fragment was measured, in which the Dai nationality was included. _measurements from a patient and a 22 kDa fragment of alpha gamma_were used to calculate the activity of the sample_;;;;;;;;;;;;;;;;;;. Use of methods for diagnosing and monitoring diseases___and 22 kDa fragments were used as biomarkers for a-gamma__barriers related to___.
展开▼